NOW Vitamin K2 100mcg Caps 60’s in Kenya

Product Summary

A targeted cardiovascular and bone health supplement delivering 100mcg of Vitamin K2 (as Menaquinone-7/MK-7) per vegetarian capsule. This fat-soluble vitamin activates proteins that direct calcium to bones (not arteries), supporting skeletal integrity and vascular health. The 60-capsule bottle offers a 2-month supply, ideal for addressing Kenya’s rising rates of osteoporosis and cardiovascular disease.

Key Benefits

• Bone Density Optimization: Activates osteocalcin to bind calcium into bones, reducing fracture risk.
• Cardiovascular Protection: Inhibits arterial calcification by activating Matrix Gla Protein (MGP).
• Synergy with Vitamin D: Maximizes calcium utilization when paired with D3 (critical for Kenyans with high D3 deficiency).
• Long-Lasting Action: MK-7 has a 72-hour half-life for sustained benefits.
• Vitamin K2 Deficiency Correction: Addresses scarcity in Kenyan diets (limited fermented foods).

Composition

• Active Ingredient per Capsule:
  • Vitamin K2 (as Menaquinone-7): 100mcg
    • Form Advantage: MK-7 has superior bioavailability vs. K1 or MK-4.
• Other Ingredients:
  • Cellulose (vegetable capsule), magnesium stearate (vegetable source), silica.
• Free From:
  • Gluten, GMOs, dairy, soy, nuts, artificial additives.
• Bioavailability:
  • Fat-soluble; best absorbed with dietary fats.

How to Use

• Dosage: Take 1 capsule daily with a fat-containing meal.
• Critical Timing:
  • With dinner (supports overnight calcium metabolism).
  • Avoid evening doses if sensitive (may disrupt sleep).
• Duration:
  • Maintenance: Safe for long-term use.
  • Therapeutic Use: 1 capsule daily for 3–6 months for deficiency correction.
• Note:
  • Do not exceed 1 capsule daily without medical supervision.
  • Take with healthy fats (e.g., avocado, nuts, olive oil).

Potential Side Effects

• Generally Safe: Well-tolerated at 100mcg/day.
• Possible Reactions:
  • Mild digestive upset or skin rash (rare).
• Serious Risks:
  • Anticoagulant Interactions: Reduces efficacy of warfarin, aspirin, or herbal blood thinners (e.g., mukombero).
  • Kidney/Liver Stress: Risk with pre-existing conditions or high doses (>200mcg/day).
• Precautions:
  • Avoid if:
    • Taking blood thinners (e.g., warfarin, clopidogrel) or anticonvulsants.
    • History of stroke, blood clots, or liver/kidney disease.
  • Consult a doctor if:
    • Pregnant/nursing (safe at RDA: 90mcg daily; high doses require monitoring).
    • On antibiotics (e.g., cephalosporins) or cholesterol meds.

Frequently Asked Questions (FAQs)

1. How long does one bottle last?

At 1 capsule daily, a 60-count bottle lasts 60 days (2 months).

2. Why MK-7 instead of other K2 forms?

• MK-7: 72-hour half-life (sustained action); 1 capsule/day suffices.
• MK-4: 1–2 hour half-life (requires multiple doses/day).

3. Can I take this without Vitamin D?

Yes, but D3 + K2 is ideal. D3 absorbs calcium; K2 directs it to bones.

4. Will it interact with malaria meds?

No. Safe with artemisinin-based therapies. Avoid with quinine (theoretical interaction).

5. How does this benefit Kenyan users?

• Osteoporosis Prevention: Critical for 60% of Kenyan women >50 with low bone mass.
• Heart Health: Counters arterial calcification (13% of Kenyan deaths are cardiovascular).
• Dietary Gap: Corrects K2 scarcity in maize/ugali-heavy diets.

6. Can children use this?

Yes for children 4+. Use 1 capsule daily. Under 4: Consult pediatrician (dose: 45–60mcg).

7. Will it cause blood clots?

No. K2 prevents calcification but doesn’t cause clotting.

8. Can I open the capsule?

Yes. Mix powder with fatty foods (e.g., peanut butter, avocado) if swallowing capsules is difficult.

Who Can Benefit?

• Adults with osteopenia/osteoporosis (e.g., postmenopausal women, elderly).
• Individuals with cardiovascular risks (hypertension, diabetes, family history of heart disease).
• People taking high-dose Vitamin D3 without K2 (common in Kenya).
• Those with low K2 intake (limited fermented foods like natto or hard cheeses).
• Not for: Those on blood thinners or with clotting disorders.